How Much Did Keranova Raise?
Funding & Key Investors

Keranova, a French company specializing in ophthalmic surgical instruments, has secured significant enterprise-level funding, with its total capital raised standing at $31.1M. The company recently announced a major strategic investment of $26.5M, underscoring its growth trajectory and market potential in the advanced medical device sector.

The latest financing round follows a Series B round in September 2019, indicating continued investor confidence in Keranova's innovative surgical solutions.

What is Keranova?

Keranova
ManufacturingMedical Devices & Equipment

Founded in 2015 and headquartered in Saint Etienne, France, Keranova is dedicated to developing cutting-edge instruments for ophthalmic surgery. The company operates on a global scale, providing advanced tools that aim to enhance precision and outcomes in eye procedures. Its focus on innovation positions it as a key player in the rapidly evolving field of medical technology, particularly within the specialized area of ophthalmology.

How much funding has Keranova raised?

Keranova has raised a total of $31.1M across 2 funding rounds:

2016

Series A

$4.5M

2019

Series B

$26.5M

Series A (2016): $4.6M with participation from CEA Investissement, Merieux Developpement, and Bpifrance

Series B (2019): $26.5M led by Tourrette Investissement, Supernova Invest, Merieux Equity Partners, and Financiere Arbevel

Key Investors in Keranova

CEA Investissement

CEA Investissement is a subsidiary of CEA focused on investing in early-stage start-ups leveraging CEA technologies, particularly in deeptech sectors. They aim to support scientific and commercial growth.

Merieux Developpement

Mérieux Développement specializes in venture capital and growth equity in healthcare and nutrition, supporting entrepreneurs with innovative global products and leveraging its international network.

Bpifrance

Bpifrance finances companies across all development stages with credit, guarantees, and equity, supporting innovation, international expansion, and export activities for French businesses.

What's next for Keranova?

The substantial enterprise-level backing and recent strategic investment suggest Keranova is poised for significant expansion and further product development. This capital infusion is likely to fuel advancements in its instrument technology, potentially enabling the company to scale its global operations, increase market penetration, and explore new applications for its ophthalmic surgical solutions. The company's trajectory indicates a move towards solidifying its position as a leader in the ophthalmic surgical instrument market.

See full Keranova company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Building MaterialsManufacturing
ManufacturingPhotographic & Optical Equipment
Food & BeverageManufacturingHospitalityRestaurant Reservations
Industrial Machinery & EquipmentManufacturingBusiness ServicesSoftware Testing

Frequently Asked Questions Regarding Keranova Financial Insights

What are the most recent funding rounds that Keranova has completed, and what were the funding rounds?
Keranova has recently completed 2 funding rounds: Series B on Sep 10, 2019, Series A on Apr 10, 2016.
What is the total amount of funding Keranova has raised to date?
Keranova has raised a total of $31.1M in funding to date.
How many funding rounds has Keranova completed?
Keranova has completed 2 funding rounds.
How much funding did Keranova raise in its most recent funding round?
Keranova raised $26.5M in its most recent funding round.
Who are the lead investors in Keranova's latest funding round?
The lead investor in Keranova's latest funding round was Tourrette Investissement. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Keranova's history?
The largest funding round in Keranova's history was $26.5M.
See more information about Keranova